Ibrahim Assi - Search Results

Year	Number of Results
2015	1
2016	5
2017	5
2018	2
2019	4
2020	5
2021	6
2022	3
2023	8
2024	6

1

A Global Assessment of Eye Health and Quality of Life: A Systematic Review of Systematic Reviews.

Assi L, Chamseddine F, Ibrahim P, Sabbagh H, Rosman L, Congdon N, Evans J, Ramke J, Kuper H, Burton MJ, Ehrlich JR, Swenor BK. Assi L, et al. JAMA Ophthalmol. 2021 May 1;139(5):526-541. doi: 10.1001/jamaophthalmol.2021.0146. JAMA Ophthalmol. 2021. PMID: 33576772 Free PMC article. Review.

2

Nerve blocks for occipital headaches: A systematic review and meta-analysis.

Evans AG, Joseph KS, Samouil MM, Hill DS, Ibrahim MM, Assi PE, Joseph JT, Kassis SA. Evans AG, et al. J Anaesthesiol Clin Pharmacol. 2023 Apr-Jun;39(2):170-180. doi: 10.4103/joacp.JOACP_62_21. Epub 2023 Apr 25. J Anaesthesiol Clin Pharmacol. 2023. PMID: 37564833 Free PMC article. Review.

3

Desmoid-type fibromatosis: Current therapeutic strategies and future perspectives.

Ibrahim R, Assi T, Khoury R, Ngo C, Faron M, Verret B, Lévy A, Honoré C, Hénon C, Le Péchoux C, Bahleda R, Le Cesne A. Ibrahim R, et al. Cancer Treat Rev. 2024 Feb;123:102675. doi: 10.1016/j.ctrv.2023.102675. Epub 2023 Dec 25. Cancer Treat Rev. 2024. PMID: 38159438 Review.

4

Targeting RET mutation in medullary thyroid cancer.

Assi T, Tikriti Z, Shayya A, Ibrahim R. Assi T, et al. Pharmacogenomics. 2024 Feb;25(3):113-115. doi: 10.2217/pgs-2023-0234. Epub 2024 Mar 7. Pharmacogenomics. 2024. PMID: 38450459 No abstract available.

5

Ipilimumab and nivolumab: the 'new kid on the block' in advanced angiosarcoma.

Assi T, Ibrahim R, Ibrahim T, Khoury R, Cesne AL. Assi T, et al. Immunotherapy. 2023 Oct;15(14):1089-1091. doi: 10.2217/imt-2023-0110. Epub 2023 Aug 10. Immunotherapy. 2023. PMID: 37585663 No abstract available.

6

Should we screen patients with hematologic malignancies for COVID-19?

Rassy E, Khoury-Abboud RM, Ibrahim N, Assi T, Samra B, Hanna C, Karak FE, Ghosn M. Rassy E, et al. Hematol Oncol. 2020 Dec;38(5):648-653. doi: 10.1002/hon.2780. Epub 2020 Aug 8. Hematol Oncol. 2020. PMID: 32779823 Free PMC article. Review.

7

KRAS G12C mutation: from black sheep to key player in pancreatic cancer treatment.

Ibrahim R, Khoury R, Ibrahim T, Assi T, Cesne AL. Ibrahim R, et al. Future Oncol. 2023 Mar;19(7):485-488. doi: 10.2217/fon-2023-0067. Epub 2023 Mar 22. Future Oncol. 2023. PMID: 36946253 No abstract available.

8

NALIRIFOX in the upfront setting of metastatic pancreatic cancer: can FOLFIRINOX finally be dethroned?

Khoury R, Ibrahim R, Ibrahim T, Cesne AL, Assi T. Khoury R, et al. Future Oncol. 2023 Mar;19(9):617-620. doi: 10.2217/fon-2023-0088. Epub 2023 May 2. Future Oncol. 2023. PMID: 37129008 No abstract available.

9

Genomic Assays in Node Positive Breast Cancer Patients: A Review.

Bou Zerdan M, Ibrahim M, Nakib CE, Hajjar R, Assi HI. Bou Zerdan M, et al. Front Oncol. 2021 Feb 16;10:609100. doi: 10.3389/fonc.2020.609100. eCollection 2020. Front Oncol. 2021. PMID: 33665165 Free PMC article. Review.

10

Dilemma of first line regimens in metastatic pancreatic adenocarcinoma.

Ghosn M, Ibrahim T, Assi T, El Rassy E, Kourie HR, Kattan J. Ghosn M, et al. World J Gastroenterol. 2016 Dec 14;22(46):10124-10130. doi: 10.3748/wjg.v22.i46.10124. World J Gastroenterol. 2016. PMID: 28028360 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

39 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year